QA: Timber Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001504167_2023_Timber_Pharmaceuticals_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001504167, Timber Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 9,813,129
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 19,373
3 remainder_Assets 443,466
4 LiabilitiesCurrent 5,041,480
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,016,615
9 ResearchAndDevelopmentExpense 9,301,958
10 remainder_Expenses 4,007,600
11 remainder_Revenues 83,177
12 remainder_NetIncome -136,454
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,275,968
1 Liabilities 5,041,480
2 Expenses 19,326,173
3 Revenues 83,177
4 StockholdersEquity 5,234,488
5 NetIncome -19,379,450
6 ComprehensiveNetIncome -19,379,450
7 BaseVar 17,431,626
8 EconomicCapitalRatio -1.35

Edgar->Model Mapping

Feature Distribution

Change over Time